Entry - #233690 - GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4; CGD4 - OMIM
# 233690

GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4; CGD4


Alternative titles; symbols

GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE
CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-NEGATIVE
CGD DUE TO DEFICIENCY OF THE ALPHA SUBUNIT OF CYTOCHROME b
CYBA DEFICIENCY


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
16q24.2 Chronic granulomatous disease 4, autosomal recessive 233690 AR 3 CYBA 608508
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
RESPIRATORY
Lung
- Pneumonia due to immunodeficiency
ABDOMEN
Liver
- Hepatic abscesses due to immunodeficiency
- Hepatomegaly
Spleen
- Splenomegaly
Gastrointestinal
- Perirectal abscesses due to immunodeficiency
SKELETAL
- Osteomyelitis due to immunodeficiency
SKIN, NAILS, & HAIR
Skin
- Dermatitis, infectious, due to immunodeficiency Impetigo
- Eczematoid dermatitis
- Discoid lupus in carriers or adults with mild disease
MUSCLE, SOFT TISSUES
- Cellulitis due to immunodeficiency
IMMUNOLOGY
- Bacterial infections, recurrent
- Fungal infections, recurrent
- Absence of bactericidal oxidative 'respiratory burst' in phagocytes
- Abscess formation in any organ
- Lymphadenitis
- Lymphadenopathy
- Aspergillus infections
- Klebsiella infections
- Staphylococcus aureus infections
- E. coli infections
- Burkholderia cepacia infections
- Serratia marcescens infections
- Tissue biopsy shows granulomas
- Biopsy shows lipid-laden macrophages
LABORATORY ABNORMALITIES
- Deficiency or absence of cytochrome b(-245)
- Deficiency or absence of p91-phox (300481) protein
- Deficiency or absence of p22-phox protein
- Negative nitroblue tetrazolium (NBT) reduction test
- Decreased activity of NADPH oxidase
MISCELLANEOUS
- Onset usually in first decade
- Four types of CGD with basically identical clinical phenotypes
- X-linked recessive cytochrome b-negative CGD (306400)
- Autosomal recessive cytochrome b-positive CGD, type I (233700)
- Autosomal recessive cytochrome b-positive CGD, type II (233710)
MOLECULAR BASIS
- Caused by mutation in the cytochrome b(-245) alpha subunit gene (CYBA, 608508.0001)

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive chronic granulomatous disease-4 (CGD4) is caused by homozygous or compound heterozygous mutation in the CYBA gene (608508), which encodes the p22-phox protein, on chromosome 16q24.

For a general phenotypic description and a discussion of genetic heterogeneity of chronic granulomatous disease, see X-linked CGD (CGDX; 306400).


Description

Chronic granulomatous disease is a genetically heterogeneous immunodeficiency disorder resulting from an inability of phagocytes to kill microbes that they have ingested. This impairment in killing is caused by any of several defects in the NADPH oxidase enzyme complex which generates the microbicidal 'respiratory burst.'


Clinical Features

Baehner and Nathan (1968) observed a 17-year-old female born of first cousins who showed a clinical course and leukocyte behavior in vitro like those in affected males with X-linked CGD. Chromosomes were normal. The nitroblue tetrazolium (NBT) test of leukocytes was normal in all relatives.

Yamada et al. (2000) reported a 33-year-old Japanese woman with cytochrome b-negative CGD who had recurrent pneumonia and osteomyelitis caused by various bacteria and Aspergillus. At the age of 33 years, she had renal insufficiency as a result of the nephrotoxic side effects of antifungal drugs and was being treated with hemodialysis. Her parents were related.

Stasia et al. (2002) reported a 5-year-old girl who presented with recurrent bacterial infections and mycosis since the first month of life. The parents were unrelated but lived in a small isolated village in which autarky was said to have existed for several generations.

Teimourian et al. (2008) reported 8 patients from 7 unrelated consanguineous Iranian families with cytochrome b-negative CGD. Patients had a clinical history of recurrent severe infections, including pneumonia, lymphadenitis, liver abscesses, and pyodermatitis. Four of the patients presented before 1 year of age. Genetic analysis identified homozygous mutation or deletion of the CYBA gene (see, e.g., 608508.0012) in all patients.


Biochemical Features

By somatic cell hybridization, Weening et al. (1985) demonstrated an autosomal form of CGD in which cytochrome b was diminished. Among the children of first-cousin parents, 2 sisters and a brother had CGD with granulocytes that did not respond with a metabolic burst to various stimuli and did not kill catalase-positive microorganisms. The magnitude of the cytochrome b signal in the optical spectrum of these leukocytes was less than 4% of normal; the amount of covalently bound flavin was normal. Autosomal recessive inheritance was confirmed; the granulocytes of both parents showed intermediate levels of cytochrome b signal, low-normal or subnormal oxidative reactions during stimulation, and no mosaicism in the stimulated NBT slide test. When monocytes from these patients were fused either with monocytes from a male with X-linked cytochrome b-negative CGD or with monocytes from a male with autosomal cytochrome b-positive CGD, the hybrid cells showed NBT reductase activity after stimulation with PMA. This complementation required protein synthesis. Weening et al. (1985) concluded that the expression of cytochrome b in human phagocytes is coded by at least 2 loci, one autosomal and one X-linked.

Parkos et al. (1989) found that neither cytochrome b subunit, p22-phox or p91-phox (300481), could be detected in neutrophils from 3 patients with X-linked cytochrome b-negative CGD or in 4 patients with autosomal cytochrome b-negative CGD. The authors concluded that the stable expression of either of the 2 subunits is dependent upon the other.


Clinical Management

Liese et al. (2000) evaluated the effect of antibiotic and antifungal long-term prophylaxis on the prognosis of CGD in 39 patients with different subtypes, both X-linked and autosomal recessive. Antibiotic prophylaxis with TMP-SMX significantly decreased the incidence of severe infections in patients with complete loss of cytochrome b activity but had no significant effect in patients with the other subtypes. Eight of the patients with complete absence of cytochrome b activity were also given itraconazole, and none developed fungal infections over 15.5 patient-years, whereas patients of all subtypes who received only antibiotics showed an increase in severe fungal infections. The different subtypes were also analyzed for age at diagnosis, age at first infection, and long-term survival.


Molecular Genetics

Clark et al. (1989) concluded that the form of CGD caused by mutation in the CYBA gene represents about 5% of all CGD cases.

In 3 patients with autosomal recessive cytochrome b-negative CGD, Dinauer et al. (1990) identified 4 mutations in the CYBA gene (608508.0001-608508.0004). One of the patients had been described by Baehner and Nathan (1968).

Yamada et al. (2000) performed mutation analysis on 3 female patients with cytochrome b-negative CGD and found 2 novel mutations in the CYBA gene. One patient with the severe phenotype had a homozygous nonsense mutation in exon 1 (608508.0009); the other 2 patients with mild phenotypes shared the same homozygous missense mutation in exon 2 (608508.0010). The latter 2 patients, but not the first, were demonstrated to have detectable p22-phox expression and significant granulocyte respiratory burst activity, consistent with the milder phenotype.

In a 5-year-old girl with cytochrome b-negative CGD, Stasia et al. (2002) identified a mutation in the CYBA gene (608508.0011).


Animal Model

Nakano et al. (2008) found that induced-mutant nmf333 mice were deficient in p22-phox protein due to a tyr121-to-his (Y121H) mutation in the Cyba gene. Homozygous mutant mice showed chronic granulomatous disease characterized by absence of superoxide production in phagocytes and complete absence of NADPH oxidase activity. The mutant mice were highly susceptible to fatal necrotizing B. cepacia pneumonia. In addition, mutant mice showed a severe balance disorder associated with complete absence of otoconia in the utricles and saccules of the inner ear. Transgenic expression of wildtype Cyba rescued both phenotypes. Studies on wildtype mice found Cyba expression in the endolymphatic ducts of the embryonic inner ear, which decreased by postnatal day 12. Based on these findings, Nakano et al. (2008) proposed that NOX activity in the endolymph of the embryonic inner ear regulates local ionic conditions and pH, which may favor the crystallization of calcium carbonate and thereby promote the formation of otoconia. However, the authors noted that balance disorders had not been described in humans with CYBA-associated disease.


See Also:

REFERENCES

  1. Baehner, R. L., Nathan, D. G. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. New Eng. J. Med. 278: 971-976, 1968. [PubMed: 4384563, related citations] [Full Text]

  2. Clark, R. A., Malech, H. L., Gallin, J. I., Nunoi, H., Volpp, B. D., Pearson, D. W., Nauseef, W. M., Curnutte, J. T. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. New Eng. J. Med. 321: 647-652, 1989. [PubMed: 2770793, related citations] [Full Text]

  3. de Boer, M., de Klein, A., Hossle, J.-P., Seger, R., Corbeel, L., Weening, R. S., Roos, D. Cytochrome b(558)-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b(558) light chain of the NADPH oxidase (p22-phox). Am. J. Hum. Genet. 51: 1127-1135, 1992. [PubMed: 1415254, related citations]

  4. Dinauer, M. C., Pierce, E. A., Bruns, G. A. P., Curnutte, J. T., Orkin, S. H. Human neutrophil cytochrome b light chain (p22-phox): gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J. Clin. Invest. 86: 1729-1737, 1990. [PubMed: 2243141, related citations] [Full Text]

  5. Liese, J., Kloos, S., Jendrossek, V., Petropoulou, T., Wintergerst, U., Notheis, G., Gahr, M., Belohradsky, B. H. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J. Pediat. 137: 687-693, 2000. [PubMed: 11060536, related citations] [Full Text]

  6. Nakano, Y., Longo-Guess, C. M., Bergstrom, D. E., Nauseef, W. M., Jones, S. M., Banfi, B. Mutation of the Cyba gene encoding p22(phox) causes vestibular and immune defects in mice. J. Clin. Invest. 118: 1176-1185, 2008. [PubMed: 18292807, images, related citations] [Full Text]

  7. Parkos, C. A., Dinauer, M. C., Jesaitis, A. J., Orkin, S. H., Curnutte, J. T. Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. Blood 73: 1416-1420, 1989. [PubMed: 2713485, related citations]

  8. Stasia, M. J., Bordigoni, P., Martel, C., Morel, F. A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A22-0) leading to the activation of a cryptic splice site in intron 4. Hum. Genet. 110: 444-450, 2002. [PubMed: 12073015, related citations] [Full Text]

  9. Teimourian, S., Zomorodian, E., Badalzadeh, M., Pouya, A., Kannengiesser, C., Mansouri, D., Cheraghi, T., Parvaneh, N. Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease. Brit. J. Haemat. 141: 848-851, 2008. [PubMed: 18422995, related citations] [Full Text]

  10. Weening, R. S., Corbeel, L., de Boer, M., Lutter, R., van Zwieten, R., Hamers, M. N., Roos, D. Cytochrome b deficiency in an autosomal form of chronic granulomatous disease: a third form of chronic granulomatous disease recognized by monocyte hybridization. J. Clin. Invest. 75: 915-920, 1985. [PubMed: 3980731, related citations] [Full Text]

  11. Yamada, M., Ariga, T., Kawamura, N., Ohtsu, M., Imajoh-Ohmi, S., Ohshika, E., Tatsuzawa, O., Kobayashi, K., Sakiyama, Y. Genetic studies of three Japanese patients with p22-phox-deficient chronic granulomatous disease: detection of a possible common mutant CYBA allele in Japan and a genotype-phenotype correlation in these patients. Brit. J. Haemat. 108: 511-517, 2000. [PubMed: 10759707, related citations] [Full Text]


Cassandra L. Kniffin - updated : 5/30/2008
Cassandra L. Kniffin - reorganized : 3/12/2004
Victor A. McKusick - updated : 6/7/2002
Victor A. McKusick - updated : 7/13/2000
Victor A. McKusick - updated : 9/1/1999
Lori M. Kelman - updated : 3/31/1997
Creation Date:
Victor A. McKusick : 6/3/1986
carol : 07/07/2020
carol : 07/06/2020
ckniffin : 07/02/2020
carol : 05/27/2016
terry : 6/3/2011
alopez : 2/9/2009
alopez : 2/5/2009
wwang : 1/23/2009
ckniffin : 1/15/2009
wwang : 6/17/2008
ckniffin : 5/30/2008
carol : 3/12/2004
terry : 3/12/2004
ckniffin : 3/12/2004
ckniffin : 3/11/2004
alopez : 6/12/2002
terry : 6/7/2002
carol : 9/11/2001
alopez : 7/21/2000
terry : 7/13/2000
alopez : 11/18/1999
carol : 9/23/1999
jlewis : 9/23/1999
terry : 9/1/1999
alopez : 3/31/1997
alopez : 3/31/1997
mimadm : 2/19/1994
carol : 2/18/1993
carol : 11/12/1992
supermim : 3/16/1992
carol : 1/27/1992
carol : 1/3/1992

# 233690

GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4; CGD4


Alternative titles; symbols

GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE
CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-NEGATIVE
CGD DUE TO DEFICIENCY OF THE ALPHA SUBUNIT OF CYTOCHROME b
CYBA DEFICIENCY


ORPHA: 379;   DO: 0070193;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
16q24.2 Chronic granulomatous disease 4, autosomal recessive 233690 Autosomal recessive 3 CYBA 608508

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive chronic granulomatous disease-4 (CGD4) is caused by homozygous or compound heterozygous mutation in the CYBA gene (608508), which encodes the p22-phox protein, on chromosome 16q24.

For a general phenotypic description and a discussion of genetic heterogeneity of chronic granulomatous disease, see X-linked CGD (CGDX; 306400).


Description

Chronic granulomatous disease is a genetically heterogeneous immunodeficiency disorder resulting from an inability of phagocytes to kill microbes that they have ingested. This impairment in killing is caused by any of several defects in the NADPH oxidase enzyme complex which generates the microbicidal 'respiratory burst.'


Clinical Features

Baehner and Nathan (1968) observed a 17-year-old female born of first cousins who showed a clinical course and leukocyte behavior in vitro like those in affected males with X-linked CGD. Chromosomes were normal. The nitroblue tetrazolium (NBT) test of leukocytes was normal in all relatives.

Yamada et al. (2000) reported a 33-year-old Japanese woman with cytochrome b-negative CGD who had recurrent pneumonia and osteomyelitis caused by various bacteria and Aspergillus. At the age of 33 years, she had renal insufficiency as a result of the nephrotoxic side effects of antifungal drugs and was being treated with hemodialysis. Her parents were related.

Stasia et al. (2002) reported a 5-year-old girl who presented with recurrent bacterial infections and mycosis since the first month of life. The parents were unrelated but lived in a small isolated village in which autarky was said to have existed for several generations.

Teimourian et al. (2008) reported 8 patients from 7 unrelated consanguineous Iranian families with cytochrome b-negative CGD. Patients had a clinical history of recurrent severe infections, including pneumonia, lymphadenitis, liver abscesses, and pyodermatitis. Four of the patients presented before 1 year of age. Genetic analysis identified homozygous mutation or deletion of the CYBA gene (see, e.g., 608508.0012) in all patients.


Biochemical Features

By somatic cell hybridization, Weening et al. (1985) demonstrated an autosomal form of CGD in which cytochrome b was diminished. Among the children of first-cousin parents, 2 sisters and a brother had CGD with granulocytes that did not respond with a metabolic burst to various stimuli and did not kill catalase-positive microorganisms. The magnitude of the cytochrome b signal in the optical spectrum of these leukocytes was less than 4% of normal; the amount of covalently bound flavin was normal. Autosomal recessive inheritance was confirmed; the granulocytes of both parents showed intermediate levels of cytochrome b signal, low-normal or subnormal oxidative reactions during stimulation, and no mosaicism in the stimulated NBT slide test. When monocytes from these patients were fused either with monocytes from a male with X-linked cytochrome b-negative CGD or with monocytes from a male with autosomal cytochrome b-positive CGD, the hybrid cells showed NBT reductase activity after stimulation with PMA. This complementation required protein synthesis. Weening et al. (1985) concluded that the expression of cytochrome b in human phagocytes is coded by at least 2 loci, one autosomal and one X-linked.

Parkos et al. (1989) found that neither cytochrome b subunit, p22-phox or p91-phox (300481), could be detected in neutrophils from 3 patients with X-linked cytochrome b-negative CGD or in 4 patients with autosomal cytochrome b-negative CGD. The authors concluded that the stable expression of either of the 2 subunits is dependent upon the other.


Clinical Management

Liese et al. (2000) evaluated the effect of antibiotic and antifungal long-term prophylaxis on the prognosis of CGD in 39 patients with different subtypes, both X-linked and autosomal recessive. Antibiotic prophylaxis with TMP-SMX significantly decreased the incidence of severe infections in patients with complete loss of cytochrome b activity but had no significant effect in patients with the other subtypes. Eight of the patients with complete absence of cytochrome b activity were also given itraconazole, and none developed fungal infections over 15.5 patient-years, whereas patients of all subtypes who received only antibiotics showed an increase in severe fungal infections. The different subtypes were also analyzed for age at diagnosis, age at first infection, and long-term survival.


Molecular Genetics

Clark et al. (1989) concluded that the form of CGD caused by mutation in the CYBA gene represents about 5% of all CGD cases.

In 3 patients with autosomal recessive cytochrome b-negative CGD, Dinauer et al. (1990) identified 4 mutations in the CYBA gene (608508.0001-608508.0004). One of the patients had been described by Baehner and Nathan (1968).

Yamada et al. (2000) performed mutation analysis on 3 female patients with cytochrome b-negative CGD and found 2 novel mutations in the CYBA gene. One patient with the severe phenotype had a homozygous nonsense mutation in exon 1 (608508.0009); the other 2 patients with mild phenotypes shared the same homozygous missense mutation in exon 2 (608508.0010). The latter 2 patients, but not the first, were demonstrated to have detectable p22-phox expression and significant granulocyte respiratory burst activity, consistent with the milder phenotype.

In a 5-year-old girl with cytochrome b-negative CGD, Stasia et al. (2002) identified a mutation in the CYBA gene (608508.0011).


Animal Model

Nakano et al. (2008) found that induced-mutant nmf333 mice were deficient in p22-phox protein due to a tyr121-to-his (Y121H) mutation in the Cyba gene. Homozygous mutant mice showed chronic granulomatous disease characterized by absence of superoxide production in phagocytes and complete absence of NADPH oxidase activity. The mutant mice were highly susceptible to fatal necrotizing B. cepacia pneumonia. In addition, mutant mice showed a severe balance disorder associated with complete absence of otoconia in the utricles and saccules of the inner ear. Transgenic expression of wildtype Cyba rescued both phenotypes. Studies on wildtype mice found Cyba expression in the endolymphatic ducts of the embryonic inner ear, which decreased by postnatal day 12. Based on these findings, Nakano et al. (2008) proposed that NOX activity in the endolymph of the embryonic inner ear regulates local ionic conditions and pH, which may favor the crystallization of calcium carbonate and thereby promote the formation of otoconia. However, the authors noted that balance disorders had not been described in humans with CYBA-associated disease.


See Also:

de Boer et al. (1992)

REFERENCES

  1. Baehner, R. L., Nathan, D. G. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. New Eng. J. Med. 278: 971-976, 1968. [PubMed: 4384563] [Full Text: https://doi.org/10.1056/NEJM196805022781801]

  2. Clark, R. A., Malech, H. L., Gallin, J. I., Nunoi, H., Volpp, B. D., Pearson, D. W., Nauseef, W. M., Curnutte, J. T. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. New Eng. J. Med. 321: 647-652, 1989. [PubMed: 2770793] [Full Text: https://doi.org/10.1056/NEJM198909073211005]

  3. de Boer, M., de Klein, A., Hossle, J.-P., Seger, R., Corbeel, L., Weening, R. S., Roos, D. Cytochrome b(558)-negative, autosomal recessive chronic granulomatous disease: two new mutations in the cytochrome b(558) light chain of the NADPH oxidase (p22-phox). Am. J. Hum. Genet. 51: 1127-1135, 1992. [PubMed: 1415254]

  4. Dinauer, M. C., Pierce, E. A., Bruns, G. A. P., Curnutte, J. T., Orkin, S. H. Human neutrophil cytochrome b light chain (p22-phox): gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J. Clin. Invest. 86: 1729-1737, 1990. [PubMed: 2243141] [Full Text: https://doi.org/10.1172/JCI114898]

  5. Liese, J., Kloos, S., Jendrossek, V., Petropoulou, T., Wintergerst, U., Notheis, G., Gahr, M., Belohradsky, B. H. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J. Pediat. 137: 687-693, 2000. [PubMed: 11060536] [Full Text: https://doi.org/10.1067/mpd.2000.109112]

  6. Nakano, Y., Longo-Guess, C. M., Bergstrom, D. E., Nauseef, W. M., Jones, S. M., Banfi, B. Mutation of the Cyba gene encoding p22(phox) causes vestibular and immune defects in mice. J. Clin. Invest. 118: 1176-1185, 2008. [PubMed: 18292807] [Full Text: https://doi.org/10.1172/JCI33835]

  7. Parkos, C. A., Dinauer, M. C., Jesaitis, A. J., Orkin, S. H., Curnutte, J. T. Absence of both the 91kD and 22kD subunits of human neutrophil cytochrome b in two genetic forms of chronic granulomatous disease. Blood 73: 1416-1420, 1989. [PubMed: 2713485]

  8. Stasia, M. J., Bordigoni, P., Martel, C., Morel, F. A novel and unusual case of chronic granulomatous disease in a child with a homozygous 36-bp deletion in the CYBA gene (A22-0) leading to the activation of a cryptic splice site in intron 4. Hum. Genet. 110: 444-450, 2002. [PubMed: 12073015] [Full Text: https://doi.org/10.1007/s00439-002-0720-8]

  9. Teimourian, S., Zomorodian, E., Badalzadeh, M., Pouya, A., Kannengiesser, C., Mansouri, D., Cheraghi, T., Parvaneh, N. Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease. Brit. J. Haemat. 141: 848-851, 2008. [PubMed: 18422995] [Full Text: https://doi.org/10.1111/j.1365-2141.2008.07148.x]

  10. Weening, R. S., Corbeel, L., de Boer, M., Lutter, R., van Zwieten, R., Hamers, M. N., Roos, D. Cytochrome b deficiency in an autosomal form of chronic granulomatous disease: a third form of chronic granulomatous disease recognized by monocyte hybridization. J. Clin. Invest. 75: 915-920, 1985. [PubMed: 3980731] [Full Text: https://doi.org/10.1172/JCI111792]

  11. Yamada, M., Ariga, T., Kawamura, N., Ohtsu, M., Imajoh-Ohmi, S., Ohshika, E., Tatsuzawa, O., Kobayashi, K., Sakiyama, Y. Genetic studies of three Japanese patients with p22-phox-deficient chronic granulomatous disease: detection of a possible common mutant CYBA allele in Japan and a genotype-phenotype correlation in these patients. Brit. J. Haemat. 108: 511-517, 2000. [PubMed: 10759707] [Full Text: https://doi.org/10.1046/j.1365-2141.2000.01857.x]


Contributors:
Cassandra L. Kniffin - updated : 5/30/2008
Cassandra L. Kniffin - reorganized : 3/12/2004
Victor A. McKusick - updated : 6/7/2002
Victor A. McKusick - updated : 7/13/2000
Victor A. McKusick - updated : 9/1/1999
Lori M. Kelman - updated : 3/31/1997

Creation Date:
Victor A. McKusick : 6/3/1986

Edit History:
carol : 07/07/2020
carol : 07/06/2020
ckniffin : 07/02/2020
carol : 05/27/2016
terry : 6/3/2011
alopez : 2/9/2009
alopez : 2/5/2009
wwang : 1/23/2009
ckniffin : 1/15/2009
wwang : 6/17/2008
ckniffin : 5/30/2008
carol : 3/12/2004
terry : 3/12/2004
ckniffin : 3/12/2004
ckniffin : 3/11/2004
alopez : 6/12/2002
terry : 6/7/2002
carol : 9/11/2001
alopez : 7/21/2000
terry : 7/13/2000
alopez : 11/18/1999
carol : 9/23/1999
jlewis : 9/23/1999
terry : 9/1/1999
alopez : 3/31/1997
alopez : 3/31/1997
mimadm : 2/19/1994
carol : 2/18/1993
carol : 11/12/1992
supermim : 3/16/1992
carol : 1/27/1992
carol : 1/3/1992